MindMed Archives

StaffDecember 14, 2023

The Daily Hit is a recap of the top financial news stories for Dec. 14, 2023. On The Site Exclusive Interview: Curaleaf CEO Matt Darin Discusses Path to Profitability Curaleaf has posted more than $700 million in losses in the last two years, but its CEO says it’s prepared to reverse that course. Read more […]

John SchroyerNovember 2, 2023

The company said it has enough cash to continue operations into 2026.

Adam JacksonAugust 14, 2023

The company already drew $15 million.

Debra BorchardtAugust 4, 2023

The company has high expectations for its MM-120 LSD drug.

StaffJuly 14, 2023

New FDA guidance on psychedelics changes little for researchers but could open minds and funding sources.

Debra BorchardtMay 25, 2023

The battle over the board of psychedelic company Mind Medicine (NASDAQ: MNMD) continues with the latest volley being shot by the current company roster. MineMed published a report by Greenleaf Health, Inc. assessing the company’s MM-120 (lysergide D-tartrate) development strategy. The report’s main focus is to refute the claims by the group FCM MM Holdings that […]

Debra BorchardtMay 5, 2023

Both parties accused each other of not understanding FDA processes.

Debra BorchardtMay 4, 2023